A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19
Clinical trial NCT05815498 · COMPLETED
Trial details
- NCT number
- NCT05815498
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-28
- Primary completion
- 2025-04-12
- Enrollment
- 13553
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.